These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 18275675

  • 1. Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B.
    Yoshida S, Hige S, Yoshida M, Yamashita N, Fujisawa S, Sato K, Kitamura T, Nishimura M, Chuma M, Asaka M, Chiba H.
    Ann Clin Biochem; 2008 Jan; 45(Pt 1):59-64. PubMed ID: 18275675
    [Abstract] [Full Text] [Related]

  • 2. Rapid detection of the hepatitis B virus YMDD mutant using TaqMan-minor groove binder probes.
    Hua R, Tanaka Y, Fukai K, Tada M, Seto M, Asaoka Y, Ohta M, Goto T, Kanai F, Kato N, Yoshida H, Kawabe T, Yokosuka O, Omata M.
    Clin Chim Acta; 2008 Sep; 395(1-2):151-4. PubMed ID: 18602379
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus quantification and detection of YMDD mutants in a single reaction by real-time PCR and annealing curve analysis.
    Shih YH, Yeh SH, Chen PJ, Chou WP, Wang HY, Liu CJ, Lu SF, Chen DS.
    Antivir Ther; 2008 Sep; 13(4):469-80. PubMed ID: 18672526
    [Abstract] [Full Text] [Related]

  • 4. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.
    Hosseini SY, Sabahi F, Amini-Bavil-Olyaee S, Alavian SM, Merat S.
    J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669
    [Abstract] [Full Text] [Related]

  • 5. Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy.
    Ding C, Wong VW, Chow KC, Chan HY, Hui AY, Wong GL, Lo YM, Sung JJ, Chan HL.
    Antivir Ther; 2006 Nov; 11(8):1041-9. PubMed ID: 17302374
    [Abstract] [Full Text] [Related]

  • 6. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
    Chayama K, Suzuki Y, Kobayashi M, Kobayashi M, Tsubota A, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Murashima N, Ikeda K, Kumada H.
    Hepatology; 1998 Jun; 27(6):1711-6. PubMed ID: 9620347
    [Abstract] [Full Text] [Related]

  • 7. Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.
    Kim JK, Lee HJ, Lee YJ, Chun JY, Lee IK, Lim YS, Suh DJ, Ko SY, Kim MH, Oh HB.
    J Virol Methods; 2008 Apr; 149(1):76-84. PubMed ID: 18291537
    [Abstract] [Full Text] [Related]

  • 8. Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.
    Shi M, Yang ZJ, Wang RS, Zhang H, Zhu YF, Xu YP, Lin QY, Jin LJ.
    Clin Chim Acta; 2006 Nov; 373(1-2):172-5. PubMed ID: 16814763
    [Abstract] [Full Text] [Related]

  • 9. [Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment].
    Liang WF, Yang DH, Shen YH, Xie YJ, Zhao NF.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):302-4. PubMed ID: 12773248
    [Abstract] [Full Text] [Related]

  • 10. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
    Ağca H, Sayıner AA, Sengönül A, Simşek I, Akarsu M.
    Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
    [Abstract] [Full Text] [Related]

  • 11. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM.
    Antivir Ther; 2006 Oct; 11(4):447-55. PubMed ID: 16856618
    [Abstract] [Full Text] [Related]

  • 12. [Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].
    Shin YM, Heo J, Kim GH, Kang DH, Song GA, Cho M, Yang US, Kim CM, Park HK, Jang HJ.
    Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):1-9. PubMed ID: 12657823
    [Abstract] [Full Text] [Related]

  • 13. Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR.
    Malmström S, Hannoun C, Lindh M.
    J Virol Methods; 2007 Aug; 143(2):147-52. PubMed ID: 17416427
    [Abstract] [Full Text] [Related]

  • 14. [Detection and identification of emergence of HBV YMDD motif mutation during lamivudine treatment by hybridization to an oligonucleotide array].
    Zhao W, Liu W, Liu QJ, Zhang L, Zhang HR, Liu XJ, Zhou ZX.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):339-43. PubMed ID: 15340547
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region.
    Natsuizaka M, Hige S, Ono Y, Ogawa K, Nakanishi M, Chuma M, Yoshida S, Asaka M.
    J Viral Hepat; 2005 Mar; 12(2):154-9. PubMed ID: 15720530
    [Abstract] [Full Text] [Related]

  • 16. Virological and biochemical relapse according to YMDD motif mutant type during long-term lamivudine monotherapy.
    Akuta N, Suzuki F, Kobayashi M, Matsuda M, Sato J, Takagi K, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2003 Dec; 71(4):504-10. PubMed ID: 14556262
    [Abstract] [Full Text] [Related]

  • 17. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
    Arslan U, Ural O, Findik D.
    Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888
    [Abstract] [Full Text] [Related]

  • 18. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
    Ogata N, Ichida T, Aoyagi Y, Kitajima I.
    Rinsho Byori; 2003 Apr; 51(4):313-9. PubMed ID: 12747252
    [Abstract] [Full Text] [Related]

  • 19. [High-flux detection of HBV lamivudine resistant strains by genechip and analysis of mutant hotspots in those strains].
    Li B, Zhou BP, Peng JF, Chen LY, Li LX, Wang ZQ, Wang M, Liu SY, Jiang XL.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):673-6. PubMed ID: 15623377
    [Abstract] [Full Text] [Related]

  • 20. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
    Akarsu M, Sengonul A, Tankurt E, Sayiner AA, Topalak O, Akpinar H, Abacioglu YH.
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1783-8. PubMed ID: 17074014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.